L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2012<\/year><\/dates><electronic-resource-num>10.1111\/j.1755-148x.2011.00898.x<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/3242935<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Modular engineering of L-tyrosine production in Escherichia coli.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2012<\/year><\/dates><electronic-resource-num>10.1128\/aem.06017-11<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/3255607<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><electronic-resource-num>10.1093\/neuonc\/nos300<\/electronic-resource-num><urls><related-urls><url>https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/15\/3\/341\/16861532\/nos300.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2012<\/year><\/dates><electronic-resource-num>10.2967\/jnumed.111.098590<\/electronic-resource-num><urls><related-urls><url>http:\/\/jnm.snmjournals.org\/content\/53\/7\/1048.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><electronic-resource-num>10.1093\/neuonc\/nov088<\/electronic-resource-num><urls><related-urls><url>https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/17\/9\/1293\/4172341\/nov088.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2012<\/year><\/dates><electronic-resource-num>10.2967\/jnumed.112.103325<\/electronic-resource-num><urls><related-urls><url>http:\/\/jnm.snmjournals.org\/content\/53\/9\/1367.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2011<\/year><\/dates><electronic-resource-num>10.2967\/jnumed.110.086645<\/electronic-resource-num><urls><related-urls><url>https:\/\/jnm.snmjournals.org\/content\/jnumed\/52\/6\/856.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2006<\/year><\/dates><electronic-resource-num>10.1016\/j.nucmedbio.2006.01.002<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><electronic-resource-num>10.1007\/s00259-012-2251-4<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Induction of cell death by ternary copper(II) complexes of L-tyrosine and diimines: role of coligands on DNA binding and cleavage and anticancer activity.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2009<\/year><\/dates><electronic-resource-num>10.1021\/ic801144x<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1999<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Genetically Encoding Fluorosulfate-l-tyrosine To React with Lysine, Histidine, and Tyrosine via SuFEx in Proteins in Vivo.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1021\/jacs.8b01087<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/6031228<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Efficient routine production of the 18F-labelled amino acid O-2-18F fluoroethyl-L-tyrosine.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2002<\/year><\/dates><electronic-resource-num>10.1016\/s0969-8043(02)00225-7<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2005<\/year><\/dates><electronic-resource-num>10.1007\/s00259-004-1705-8<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Positive regulation of melanin pigmentation by two key substrates of the melanogenic pathway, L-tyrosine and L-dopa.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1988<\/year><\/dates><electronic-resource-num>10.1242\/jcs.89.3.287<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><electronic-resource-num>10.1007\/s00259-014-2959-4<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Daniel A. Arber<\/author><author>Attilio Orazi<\/author><author>Robert P. Hasserjian et al.<\/author><\/authors><\/contributors><titles><title>The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia<\/title><secondary-title>Blood<\/secondary-title><\/titles><dates><year>2016<\/year><\/dates><electronic-resource-num>10.1182\/blood-2016-03-643544<\/electronic-resource-num><urls><related-urls><url>https:\/\/ashpublications.org\/blood\/article-pdf\/127\/20\/2391\/1393154\/2391.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Bernard R. Brooks<\/author><author>Charles L. Brooks<\/author><author>Alexander D. MacKerell et al.<\/author><\/authors><\/contributors><titles><title>CHARMM: The biomolecular simulation program<\/title><secondary-title>Journal of Computational Chemistry<\/secondary-title><\/titles><dates><year>2009<\/year><\/dates><electronic-resource-num>10.1002\/jcc.21287<\/electronic-resource-num><urls><related-urls><url>https:\/\/onlinelibrary.wiley.com\/doi\/pdfdirect\/10.1002\/jcc.21287<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>The homogentisate pathway: a central catabolic pathway involved in the degradation of L-phenylalanine, L-tyrosine, and 3-hydroxyphenylacetate in Pseudomonas putida.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2004<\/year><\/dates><electronic-resource-num>10.1128\/jb.186.15.5062-5077.2004<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/451635<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Genetic control of immune responses in vitro. V. Stimulation of suppressor T cells in nonresponder mice by the terpolymer L-glutamic acid 60-L-alanine 30-L-tyrosine 10 (GAT).<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1974<\/year><\/dates><electronic-resource-num>10.1084\/jem.140.3.648<\/electronic-resource-num><urls><related-urls><url>https:\/\/rupress.org\/jem\/article-pdf\/140\/3\/648\/1086460\/648.pdf<\/url><\/related-urls><\/urls><\/record>\n<\/records><\/xml>\n"

"\n\nMolGod<\/database>MOL-GOD<\/source-app>1<\/rec-number>17<\/ref-type><\/authors><\/contributors>L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2012<\/year><\/dates><electronic-resource-num>10.1111\/j.1755-148x.2011.00898.x<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/3242935<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Modular engineering of L-tyrosine production in Escherichia coli.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2012<\/year><\/dates><electronic-resource-num>10.1128\/aem.06017-11<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/3255607<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><electronic-resource-num>10.1093\/neuonc\/nos300<\/electronic-resource-num><urls><related-urls><url>https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/15\/3\/341\/16861532\/nos300.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2012<\/year><\/dates><electronic-resource-num>10.2967\/jnumed.111.098590<\/electronic-resource-num><urls><related-urls><url>http:\/\/jnm.snmjournals.org\/content\/53\/7\/1048.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><electronic-resource-num>10.1093\/neuonc\/nov088<\/electronic-resource-num><urls><related-urls><url>https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/17\/9\/1293\/4172341\/nov088.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2012<\/year><\/dates><electronic-resource-num>10.2967\/jnumed.112.103325<\/electronic-resource-num><urls><related-urls><url>http:\/\/jnm.snmjournals.org\/content\/53\/9\/1367.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2011<\/year><\/dates><electronic-resource-num>10.2967\/jnumed.110.086645<\/electronic-resource-num><urls><related-urls><url>https:\/\/jnm.snmjournals.org\/content\/jnumed\/52\/6\/856.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2006<\/year><\/dates><electronic-resource-num>10.1016\/j.nucmedbio.2006.01.002<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><electronic-resource-num>10.1007\/s00259-012-2251-4<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Induction of cell death by ternary copper(II) complexes of L-tyrosine and diimines: role of coligands on DNA binding and cleavage and anticancer activity.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2009<\/year><\/dates><electronic-resource-num>10.1021\/ic801144x<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1999<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Genetically Encoding Fluorosulfate-l-tyrosine To React with Lysine, Histidine, and Tyrosine via SuFEx in Proteins in Vivo.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1021\/jacs.8b01087<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/6031228<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Efficient routine production of the 18F-labelled amino acid O-2-18F fluoroethyl-L-tyrosine.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2002<\/year><\/dates><electronic-resource-num>10.1016\/s0969-8043(02)00225-7<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2005<\/year><\/dates><electronic-resource-num>10.1007\/s00259-004-1705-8<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Positive regulation of melanin pigmentation by two key substrates of the melanogenic pathway, L-tyrosine and L-dopa.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1988<\/year><\/dates><electronic-resource-num>10.1242\/jcs.89.3.287<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><electronic-resource-num>10.1007\/s00259-014-2959-4<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Daniel A. Arber<\/author><author>Attilio Orazi<\/author><author>Robert P. Hasserjian et al.<\/author><\/authors><\/contributors><titles><title>The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia<\/title><secondary-title>Blood<\/secondary-title><\/titles><dates><year>2016<\/year><\/dates><electronic-resource-num>10.1182\/blood-2016-03-643544<\/electronic-resource-num><urls><related-urls><url>https:\/\/ashpublications.org\/blood\/article-pdf\/127\/20\/2391\/1393154\/2391.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Bernard R. Brooks<\/author><author>Charles L. Brooks<\/author><author>Alexander D. MacKerell et al.<\/author><\/authors><\/contributors><titles><title>CHARMM: The biomolecular simulation program<\/title><secondary-title>Journal of Computational Chemistry<\/secondary-title><\/titles><dates><year>2009<\/year><\/dates><electronic-resource-num>10.1002\/jcc.21287<\/electronic-resource-num><urls><related-urls><url>https:\/\/onlinelibrary.wiley.com\/doi\/pdfdirect\/10.1002\/jcc.21287<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>The homogentisate pathway: a central catabolic pathway involved in the degradation of L-phenylalanine, L-tyrosine, and 3-hydroxyphenylacetate in Pseudomonas putida.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2004<\/year><\/dates><electronic-resource-num>10.1128\/jb.186.15.5062-5077.2004<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/451635<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Genetic control of immune responses in vitro. V. Stimulation of suppressor T cells in nonresponder mice by the terpolymer L-glutamic acid 60-L-alanine 30-L-tyrosine 10 (GAT).<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1974<\/year><\/dates><electronic-resource-num>10.1084\/jem.140.3.648<\/electronic-resource-num><urls><related-urls><url>https:\/\/rupress.org\/jem\/article-pdf\/140\/3\/648\/1086460\/648.pdf<\/url><\/related-urls><\/urls><\/record>\n<\/records><\/xml>\n"